85 related articles for article (PubMed ID: 16481266)
1. An association of multiple endocrine neoplasia 2B, a RET mutation; constipation; and low substance P-nerve fiber density in colonic circular muscle.
King SK; Southwell BR; Hutson JM
J Pediatr Surg; 2006 Feb; 41(2):437-42. PubMed ID: 16481266
[TBL] [Abstract][Full Text] [Related]
2. Isolated intestinal ganglioneuromatosis with a new mutation of RET proto-oncogene.
Nguyen AT; Zacharin MR; Smith M; Hardikar W
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):803-5. PubMed ID: 16772843
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia type 2B diagnosed on suction rectal biopsy in infancy: a report of 2 cases.
Yin M; King SK; Hutson JM; Chow CW
Pediatr Dev Pathol; 2006; 9(1):56-60. PubMed ID: 16808642
[TBL] [Abstract][Full Text] [Related]
4. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.
Dvorakova S; Vaclavikova E; Ryska A; Cap J; Vlcek P; Duskova J; Kodetova D; Holub V; Novak Z; Bendlova B
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552
[TBL] [Abstract][Full Text] [Related]
5. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
6. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].
Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H
Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813
[TBL] [Abstract][Full Text] [Related]
7. [Neural crest and multiple endocrinopathies].
Pasini A; Michiels FM; Chappuis-Flament S; Geneste O; Rossel M; Fournier L; Feunteun J; Lenoir G; Schuffenecker I; Billaud M
C R Seances Soc Biol Fil; 1996; 190(5-6):557-67. PubMed ID: 9074721
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients.
Fernández RM; Navarro E; Antiñolo G; Ruiz-Ferrer M; Borrego S
Int J Mol Med; 2006 Apr; 17(4):575-81. PubMed ID: 16525712
[TBL] [Abstract][Full Text] [Related]
9. Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis.
Brauckhoff M; Machens A; Hess S; Lorenz K; Gimm O; Brauckhoff K; Sekulla C; Dralle H
Surgery; 2008 Dec; 144(6):1044-50; discussion 1050-3. PubMed ID: 19041016
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.
Frank-Raue K; Rondot S; Raue F
Mol Cell Endocrinol; 2010 Jun; 322(1-2):2-7. PubMed ID: 20083156
[TBL] [Abstract][Full Text] [Related]
11. RET(MEN 2B) is active in the endoplasmic reticulum before reaching the cell surface.
Runeberg-Roos P; Virtanen H; Saarma M
Oncogene; 2007 Dec; 26(57):7909-15. PubMed ID: 17599050
[TBL] [Abstract][Full Text] [Related]
12. Change in the spectrum of RET mutations diagnosed between 1994 and 2006.
Frank-Raue K; Rondot S; Schulze E; Raue F
Clin Lab; 2007; 53(5-6):273-82. PubMed ID: 17605401
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2B.
Gujral TS; Singh VK; Jia Z; Mulligan LM
Cancer Res; 2006 Nov; 66(22):10741-9. PubMed ID: 17108110
[TBL] [Abstract][Full Text] [Related]
14. A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.
Vanhorne JB; Andrew SD; Harrison KJ; Taylor SA; Thomas B; McDonald TJ; Ainsworth PJ; Mulligan LM
Oncogene; 2005 Feb; 24(6):1091-7. PubMed ID: 15592530
[TBL] [Abstract][Full Text] [Related]
15. RET-mediated gene expression pattern is affected by isoform but not oncogenic mutation.
Hickey JG; Myers SM; Tian X; Zhu SJ; V Shaw JL; Andrew SD; Richardson DS; Brettschneider J; Mulligan LM
Genes Chromosomes Cancer; 2009 May; 48(5):429-40. PubMed ID: 19226610
[TBL] [Abstract][Full Text] [Related]
16. Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations.
de Groot JW; Plaza Menacho I; Schepers H; Drenth-Diephuis LJ; Osinga J; Plukker JT; Links TP; Eggen BJ; Hofstra RM
Surgery; 2006 Jun; 139(6):806-14. PubMed ID: 16782438
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.
Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB
Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527
[TBL] [Abstract][Full Text] [Related]
19. Chronic constipation: no longer stuck! Characterization of colonic dysmotility as a new disorder in children.
Hutson JM; Catto-Smith T; Gibb S; Chase J; Shin YM; Stanton M; King S; Sutcliffe J; Ong SY; Djaja S; Farmer P; Southwell B
J Pediatr Surg; 2004 Jun; 39(6):795-9. PubMed ID: 15185198
[No Abstract] [Full Text] [Related]
20. Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report.
Unruh A; Fitze G; Jänig U; Bielack S; Lochbühler H; Coerdt W
J Pediatr Surg; 2007 Sep; 42(9):1623-6. PubMed ID: 17848262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
